重症肺炎患者支气管肺泡灌洗液中miR-127-5p的表达及其诊断价值
该研究纳入2015年1月至12月宁夏医科大学总医院重症医学科收治的30例重症肺炎患者和10例术后需机械通气的非呼吸道感染患者,采集支气管肺泡灌洗液。采用miRNA芯片技术初步建立重症肺炎患者支气管肺泡灌洗液miRNA差异表达谱,筛选出40个上调miRNA和113个下调miRNA。实时荧光定量PCR测定miR-127-5p表达水平,重症肺炎患者较非呼吸道感染患者显著降低(2-ΔΔCT:0.578±0.226 vs. 1.004±0.337,t=4.552,P=0.000)。ROC曲线分析显示miR-127-5p诊断重症肺炎的AUC为0.855(95%CI 0.721-0.989,P=0.001),以0.840为临界值时敏感度和特异度分别为86.7%和70.0%,阳性似然比2.89,阴性似然比0.19。作者认为支气管肺泡灌洗液中miR-127-5p可作为诊断重症肺炎的新生物标志物。
要点
- 重症肺炎患者支气管肺泡灌洗液中miR-127-5p表达较非呼吸道感染患者显著降低(2-ΔΔCT:0.578±0.226 vs. 1.004±0.337,P=0.000)。
- miR-127-5p诊断重症肺炎的AUC为0.855(95%CI 0.721-0.989,P=0.001),以0.840为临界值时敏感度86.7%、特异度70.0%。
- 阳性似然比2.89、阴性似然比0.19,提示该指标对排除重症肺炎有一定价值。
- 该研究初步建立了重症肺炎患者支气管肺泡灌洗液miRNA差异表达谱,其中40个miRNA上调、113个miRNA下调。
- 作者认为支气管肺泡灌洗液中miR-127-5p可作为诊断重症肺炎的新生物标志物。
适用人群与场景
- 2015年1月至12月宁夏医科大学总医院重症医学科收治的30例重症肺炎患者和10例术后需机械通气的非呼吸道感染患者。
诊断标准与关键阈值
- 以支气管肺泡灌洗液miR-127-5p的2-ΔΔCT值0.840为临界值诊断重症肺炎,敏感度86.7%、特异度70.0%。
研究设计与关键结果
- 研究类型为病例对照研究,纳入30例重症肺炎患者和10例非呼吸道感染患者,共40例全部纳入最终分析。
- 重症肺炎患者支气管肺泡灌洗液miR-127-5p表达较非呼吸道感染患者显著降低(2-ΔΔCT:0.578±0.226 vs. 1.004±0.337,t=4.552,P=0.000)。
- miR-127-5p诊断重症肺炎的AUC为0.855(95%CI 0.721-0.989,P=0.001),以0.840为临界值时敏感度86.7%、特异度70.0%,阳性似然比2.89、阴性似然比0.19。
- 初步建立重症肺炎患者支气管肺泡灌洗液miRNA差异表达谱,其中40个miRNA上调、113个miRNA下调。
证据类型、等级与局限
- 证据类型为病例对照研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为支气管肺泡灌洗液中miR-127-5p可作为诊断重症肺炎的新生物标志物。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To observe differential expressions of microRNA-127-5p (miR-127-5p) in bronchoalveolar lavage fluid (BALF) of patients with severe pneumonia and the value of miR-127-5p in the diagnosis of severe pneumonia.
METHODS: Thirty severe pneumonia patients and 10 non-respiratory infection patients who needed mechanical ventilation after surgery admitted to Department of Critical Care Medicine of General Hospital of Ningxia Medical University from January to December in 2015 were enrolled, whose specimens of BALF were collected. The differential expressions of miRNA in BALF of patients in both groups were screened by miRNA chip technique to preliminarily establish miRNA differential expression profiles in BALF of severe pneumonia, and the miRNAs which were up-regulated and down-regulated were screened out. The expression levels of miR-127-5p were determined using a real-time fluorescent quantitative polymerase chain reaction (PCR). The value of miR-127-5p expression in the diagnosis of severe pneumonia was evaluated with receiver-operating characteristic curve (ROC).
RESULTS: All of the 40 patients were enrolled in the final analysis. Differential expression spectrum of miRNA in severe pneumonia patients was initially built, in which 40 miRNAs were up-regulated and 113 miRNAs were down-regulated. Compared with non-respiratory infection patients, the expressions of miR-127-5p were significantly lowered in severe pneumonia patients (2-Δ ΔCT: 0.578±0.226 vs. 1.004±0.337) with statistical difference (t = 4.552, P = 0.000). ROC curve analysis showed that the area under ROC curve (AUC) of miR-127-5p for diagnosis of severe pneumonia was 0.855 [95% confidence interval (95%CI) = 0.721-0.989, P = 0.001], with the optimal sensitivity and specificity of 86.7% and 70.0% respectively with 0.840 as the critical value, and the positive likelihood ratio was 2.89, the negative likelihood ratio was 0.19.
CONCLUSIONS: miR-127-5p in BALF could be used as a new biomarker for the diagnosis of severe pneumonia.
参考来源
- Wang Z, Liu Q, Wang X, et al. [Expressions of microRNA-127-5p in bronchoalveolar lavage fluid of patients with severe pneumonia and its diagnostic value]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017. PMID: 28743334. doi:10.3760/cma.j.issn.2095-4352.2017.07.004
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。